au.\*:("VAN BODEGRAVEN, A. A")
Results 1 to 16 of 16
Selection :
Esophagopleural fistula treated endoscopically with argon beam electro-coagulation and clipsVAN BODEGRAVEN, A. A; KUIPERS, E. J; BONENKAMP, H. J et al.Gastrointestinal endoscopy. 1999, Vol 50, Num 3, pp 407-410, issn 0016-5107Article
Myelotoxicity and hepatotoxicity during azathioprine therapyDE BOER, N. K. H; MULDER, C. J. J; VAN BODEGRAVEN, A. A et al.Netherlands journal of medicine. 2005, Vol 63, Num 11, pp 444-446, issn 0300-2977, 3 p.Article
The citrulline generation test : proposal for a new enterocyte function testPETERS, J. H. C; WIERDSMA, N. J; TEERLINK, T et al.Alimentary pharmacology & therapeutics. 2008, Vol 27, Num 12, pp 1300-1310, issn 0269-2813, 11 p.Article
Influence of 5-aminosalicylic acid on 6-thioguanosine phosphate metabolite levels: a prospective study in patients under steady thiopurine therapyDE GRAAF, P; DE BOER, Nkh; WONG, D. R et al.British journal of pharmacology. 2010, Vol 160, Num 5, pp 1083-1091, issn 0007-1188, 9 p.Article
Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis. CommentaryMEDDINGS, Jon; WAPENAAR, M. C; DIJKSTRA, G et al.Gut. 2008, Vol 57, Num 4, issn 0017-5749, 438-440, 463-467 [8 p.]Article
Long-term follow-up of two patients with metastatic neuroendocrine tumours treated with octreotideDE LOOSDRECHT, A. A. V; VAN BODEGRAVEN, A. A; SEPERS, J. M et al.Netherlands journal of medicine. 1998, Vol 53, Num 3, pp 118-123, issn 0300-2977Conference Paper
Long-term follow-up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel diseaseDE MEIJ, T. G. J; JHARAP, B; KNEEPKENS, C. M. F et al.Alimentary pharmacology & therapeutics. 2013, Vol 38, Num 1, pp 38-43, issn 0269-2813, 6 p.Article
Tioguanine in the treatment of refractory coeliac disease ― a single centre experienceTACK, G. J; VAN ASSELDONK, D. P; VAN WANROOIJ, R. L. J et al.Alimentary pharmacology & therapeutics. 2012, Vol 36, Num 3, pp 274-281, issn 0269-2813, 8 p.Article
High frequency of early colorectal cancer in inflammatory bowel disease. CommentaryBERNSTEIN, Charles N; LUTGENS, M. W. M. D; OLDENBURG, B et al.Gut. 2008, Vol 57, Num 9, issn 0017-5749, 1194-1196, 1246-1251 [9 p.]Article
Predictive value of inflammatory and coagulation parameters in the course of severe ulcerative colitisLINSKENS, R. K; VAN BODEGRAVEN, A. A; SCHOORL, M et al.Digestive diseases and sciences. 2001, Vol 46, Num 3, pp 644-648, issn 0163-2116Conference Paper
Addition of low-dose oral cyclosporine in severe ulcerative colitis - pharmacokinetics and clinical outcome report of twelve casesVAN BODEGRAVEN, A. A; LINSKENS, R. K; VAN HAELST, I. M. M et al.Journal of clinical gastroenterology. 1998, Vol 27, Num 1, pp 72-73, issn 0192-0790Article
Limited stability of thiopurine metabolites in blood samples: Relevant in research and clinical practiseDE GRAAF, P; VOS, R. M; DE BOER, N. H. K et al.Journal of chromatography. B. 2010, Vol 878, Num 19, pp 1437-1442, issn 1570-0232, 6 p.Article
Molecular prediction of disease risk and severity in a larqe Dutch Crohn's disease cohortWEERSMA, R. K; STOKKERS, P. C. F; VAN DER STEEGE, G et al.Gut. 2009, Vol 58, Num 3, pp 388-395, issn 0017-5749, 8 p.Article
Guidelines for treatment with infliximab for Crohn's diseaseHOMMES, D. W; OLDENBURG, B; VAN BODEGRAVEN, A. A et al.Netherlands journal of medicine. 2006, Vol 64, Num 7, pp 219-229, issn 0300-2977, 11 p.Article
Distribution of mesalazine enemas in active and quiescent ulcerative colitisVAN BODEGRAVEN, A. A; BOER, R. O; LOURENS, J et al.Alimentary pharmacology & therapeutics. 1996, Vol 10, Num 3, pp 327-332, issn 0269-2813Article
Fibrinoloytic split products, fibrinolysis, and factor XIII activity in inflammatory bowel diseaseVAN BODEGRAVEN, A. A; TUYNMAN, H. A. R. E; SCHOORL, M et al.Scandinavian journal of gastroenterology. 1995, Vol 30, Num 6, pp 580-585, issn 0036-5521Article